← Leaderboards
Esther H Chang
Georgetown University
$5,500,996
Attributed
$6,645,583
Total exposure
9
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $633.2K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,645,583 · 9
By mechanism
R01$3,462,235 · 2
R42$1,794,326 · 2
R41$978,341 · 4
U43$410,681 · 1
Top collaborators
- Matthew T Freedman3 shared
- Robert F Place3 shared
Most similar at Georgetown University
Same institution · by research overlap
- Matthew T Freedman$939,247
- Shih-Chung B Lo$2,700,700
- Paola Barbara$2,451,561
- Gen Yin$435,000
Others in their field
Top investigators on “Liposomes”
- Katherine W Ferrara · Stanford University$21,313,923
- James C. Paulson · Scripps Research Institute$15,907,257
- David D McPherson · Northwestern University$13,361,624
- Michael B Zwick · Scripps Research Institute, The$13,172,478
- Gary Fujii · Molecular Express, Inc.$12,568,015
- Casey Koontz · Leidos, Inc.$11,293,734
Research focus
LiposomesAthymic MouseGene TherapyP53 Gene /ProteinUptakeMouse ModelXenograft ProcedureResponseToxic EffectBaseIn VivoNeoplasm /Cancer TransplantationGene Delivery SystemMalignant NeoplasmsDoseCellsBiologicalFutureIn VitroNeoplasm MetastasisTumorImmunoglobulin FragmentsCancer CellLead
Grant awards (17)
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement Therapy for Multi-drug Resistant Cancer Treatment$61,463
U43 · FY2019 · CA
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement$49,951
U43 · FY2018 · CA
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement Therapy for Multi-drug Resistant Cancer Treatment$299,267
U43 · FY2017 · CA
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer$630,627
R01 · FY2010 · CA · contact PI
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer$633,229
R01 · FY2009 · CA · contact PI
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer$614,637
R01 · FY2008 · CA · contact PI
A Tumor-Specific Nanoimmunocomplex Markedly Improves MR Imaging$478,857
R41 · FY2006 · CA · contact PI
A Dual Molecular/Tumor Targeting Therapy for PanCa$588,264
R42 · FY2005 · CA
A Dual Molecular/Tumor Targeting Therapy for PanCa$571,402
R42 · FY2004 · CA
Enhancement of Tumor-Targeted Transgene Expression$201,742
R41 · FY2004 · CA
Immunoliposome-Mediated Gene Therapy for Prostate Cancer$317,330
R42 · FY2003 · CA
A Dual Molecular/Targeting Therapy for PanCa$158,980
R41 · FY2003 · CA
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN$591,665
R01 · FY2002 · DE
Immunoliposome-Mediated Gene Therapy for Prostate Cancer$317,330
R42 · FY2002 · CA
Targeting Stealth Liposome for Cancer Gene Therapy$138,762
R41 · FY2002 · CA
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN$575,738
R01 · FY2001 · DE
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN$416,339
R01 · FY2000 · DE